Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Flaxseed and cardiovascular risk.
Bloedon LT, Szapary PO. Bloedon LT, et al. Nutr Rev. 2004 Jan;62(1):18-27. doi: 10.1111/j.1753-4887.2004.tb00002.x. Nutr Rev. 2004. PMID: 14995053 Review.
A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesity.
Foster GD, Shantz KL, Vander Veur SS, Oliver TL, Lent MR, Virus A, Szapary PO, Rader DJ, Zemel BS, Gilden-Tsai A. Foster GD, et al. Among authors: szapary po. Am J Clin Nutr. 2012 Aug;96(2):249-54. doi: 10.3945/ajcn.112.037895. Epub 2012 Jun 27. Am J Clin Nutr. 2012. PMID: 22743313 Free PMC article. Clinical Trial.
Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.
Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, Szapary PO. Bloedon LT, et al. J Am Coll Nutr. 2008 Feb;27(1):65-74. doi: 10.1080/07315724.2008.10719676. J Am Coll Nutr. 2008. PMID: 18460483 Clinical Trial.
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
Ky B, Burke A, Tsimikas S, Wolfe ML, Tadesse MG, Szapary PO, Witztum JL, FitzGerald GA, Rader DJ. Ky B, et al. J Am Coll Cardiol. 2008 Apr 29;51(17):1653-62. doi: 10.1016/j.jacc.2008.01.026. J Am Coll Cardiol. 2008. PMID: 18436117 Clinical Trial.
Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models.
Pellizzon MA, Billheimer JT, Bloedon LT, Szapary PO, Rader DJ. Pellizzon MA, et al. J Am Coll Nutr. 2007 Feb;26(1):66-75. doi: 10.1080/07315724.2007.10719587. J Am Coll Nutr. 2007. PMID: 17353585
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ. Cuchel M, et al. N Engl J Med. 2007 Jan 11;356(2):148-56. doi: 10.1056/NEJMoa061189. N Engl J Med. 2007. PMID: 17215532 Clinical Trial.
Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.
Samaha FF, Szapary PO, Iqbal N, Williams MM, Bloedon LT, Kochar A, Wolfe ML, Rader DJ. Samaha FF, et al. Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):624-30. doi: 10.1161/01.ATV.0000200136.56716.30. Epub 2005 Dec 15. Arterioscler Thromb Vasc Biol. 2006. PMID: 16357312 Clinical Trial.
Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.
Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ. Szapary PO, et al. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. doi: 10.1161/01.ATV.0000195790.24531.4f. Epub 2005 Nov 10. Arterioscler Thromb Vasc Biol. 2006. PMID: 16284192 Clinical Trial.
Physical activity and its effects on lipids.
Szapary PO, Bloedon LT, Foster GD. Szapary PO, et al. Curr Cardiol Rep. 2003 Nov;5(6):488-92. doi: 10.1007/s11886-003-0112-2. Curr Cardiol Rep. 2003. PMID: 14558992 Review.
28 results
Jump to page
Feedback